"There is just no standard of care." Emily Hilliard, a spokesperson for the Department of Health and Human Services, told KFF Health News that compounded drugs "should only be used in patients whose medical needs cannot be met by an FDA-approved drug." Hilliard said the agency urges "consumers to be vigilant and know the source of their medicine." Understanding the risks While weight loss drugs have helped millions of people lose weight, they're not without risk, the data shows
& Fujii, T
Gao, H., Li, X., Chen, X., Hai, D., Wei, C., Zhang, L., & Li, P
He is also a senior scientist at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital in Toronto
10.1016/j.ijpharm.2025.126315 18 MenzelC.HolzeisenT.LaffleurF.ZaichikS.AbdulkarimM.GumbletonM.et al (2018)
doi: 10.1002/dmrr.3070 Summary Keywords GLP-1 receptor agonists, thyroid disorders, thyroid cancer, meta-analysis, randomized controlled trials Citation Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X and Liu J (2022) Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials
